Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Compound Houttuynia Tablets
- Development stage
- Unknown
- Lead developer
- Jilin Fukang Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Compound Houttuynia Tablets is a traditional Chinese medicine (TCM) oral formulation developed and manufactured by Jilin Fukang Pharmaceutical. It is a multi-ingredient herbal preparation primarily composed of *Houttuynia cordata* (Yuxingcao), supplemented with other botanical extracts including *Scutellaria baicalensis* (Huangqin), *Forsythia suspensa* (Lianqiao), *Isatis tinctoria* (Banlangen), and *Lonicera japonica* (Jinyinhua). The drug is indicated for clearing heat and detoxifying the body, specifically for the treatment of respiratory conditions such as acute tonsillitis, pharyngitis, and upper respiratory tract infections. Its therapeutic effects are attributed to the synergistic action of various phytochemicals, such as decanoyl acetaldehyde (houttuynin) and baicalin, which exhibit broad-spectrum antimicrobial, antiviral, and anti-inflammatory properties.
- Brand names
- Compound Houttuynia Tablets
- Other names
- Fufang Yuxingcao PianCompound Houttuynia Cordata Tablets复方鱼腥草片
02
Targets
AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)EGFR (Epidermal growth factor receptor)IL-6 (Interleukin 6)JUN (Transcription factor Jun)MMP1 (Matrix metalloproteinase-1)MMP9 (Matrix metalloproteinase-9)TP53 (Cellular Tumor Antigen p53 R175H)VEGFA (Vascular endothelial growth factor A)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)TNFA (Tumor necrosis factor alpha (soluble))
Beyond the preview
Go deeper on Compound Houttuynia Tablets.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Compound Houttuynia Tablets.